Fund profile
Tickers
LYFCX, LYFIX, LYFAX
Fund manager
Total assets
$104.64 mm
Liabilities
$409.65 k
Net assets
$104.23 mm
Number of holdings
55.00
55 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
FIRST AM-TR OB-X | 11.79 mm | 11.79 mm principal | 11.31 | Short-term investment vehicle | Long | USA |
GLPG Galapagos NV | 4.27 mm | 105.00 k shares | 4.09 | Common equity | Long | Belgium |
BCRX Biocryst Pharmaceuticals Inc. | 4.04 mm | 675.00 k shares | 3.88 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 3.96 mm | 117.50 k shares | 3.80 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 3.96 mm | 18.00 k shares | 3.80 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 3.94 mm | 122.00 k shares | 3.78 | Common equity | Long | USA |
EMBC Embecta Corp | 3.79 mm | 200.00 k shares | 3.63 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 3.78 mm | 127.50 k shares | 3.63 | Common equity | Long | USA |
CHRS Coherus Biosciences Inc | 3.33 mm | 1.00 mm shares | 3.19 | Common equity | Long | USA |
WBA Walgreens Boots Alliance Inc | 3.13 mm | 120.00 k shares | 3.01 | Common equity | Long | USA |
ARGX Argen X SE | 2.95 mm | 7.75 k shares | 2.83 | Common equity | Long | Netherlands |
ABVX Abivax S.A. | 2.86 mm | 267.50 k shares | 2.75 | Common equity | Long | France |
QURE uniQure N.V. | 2.85 mm | 421.03 k shares | 2.73 | Common equity | Long | Netherlands |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 2.80 mm | 245.00 k shares | 2.69 | Common equity | Long | USA |
URGN UroGen Pharma Ltd | 2.33 mm | 155.00 k shares | 2.23 | Common equity | Long | Israel |
PFE Pfizer Inc. | 2.30 mm | 80.00 k shares | 2.21 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 2.22 mm | 151.00 k shares | 2.13 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 1.99 mm | 140.00 k shares | 1.91 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 1.93 mm | 220.00 k shares | 1.86 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 1.81 mm | 112.50 k shares | 1.74 | Common equity | Long | USA |
DCGO DocGo Inc | 1.73 mm | 310.00 k shares | 1.66 | Common equity | Long | USA |
MDT Medtronic Plc | 1.69 mm | 20.50 k shares | 1.62 | Common equity | Long | Ireland |
KALV KalVista Pharmaceuticals Inc | 1.68 mm | 137.00 k shares | 1.61 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 1.63 mm | 90.00 k shares | 1.56 | Common equity | Long | UK |
IMVT Immunovant Inc | 1.60 mm | 38.00 k shares | 1.54 | Common equity | Long | USA |
VYNE VYNE Therapeutics Inc | 1.56 mm | 668.15 k shares | 1.49 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 1.48 mm | 50.00 k shares | 1.42 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 1.43 mm | 20.00 k shares | 1.37 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 1.40 mm | 100.00 k shares | 1.34 | Common equity | Long | USA |
BEIGENE LTD-ADR
|
1.35 mm | 7.50 k shares | 1.30 | Common equity | Long | Cayman Islands |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 1.35 mm | 14.00 k shares | 1.30 | Common equity | Long | USA |
GSK GSK Plc | 1.30 mm | 35.00 k shares | 1.24 | Common equity | Long | UK |
JAZZ Jazz Pharmaceuticals plc | 1.29 mm | 10.50 k shares | 1.24 | Common equity | Long | Ireland |
GPCR Structure Therapeutics Inc | 1.22 mm | 30.00 k shares | 1.17 | Common equity | Long | Cayman Islands |
VSTM Verastem Inc | 1.22 mm | 150.00 k shares | 1.17 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 1.12 mm | 40.00 k shares | 1.08 | Common equity | Long | UK |
VRNA Verona Pharma Plc | 1.11 mm | 56.00 k shares | 1.07 | Common equity | Long | UK |
KRTX Karuna Therapeutics Inc | 1.11 mm | 3.50 k shares | 1.06 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 1.06 mm | 25.00 k shares | 1.02 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc | 973.13 k | 1.13 mm shares | 0.93 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 814.06 k | 26.00 k shares | 0.78 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 688.59 k | 8.50 k shares | 0.66 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 687.90 k | 30.00 k shares | 0.66 | Common equity | Long | USA |
NUVB Nuvation Bio Inc - Ordinary Shares | 679.50 k | 450.00 k shares | 0.65 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 617.65 k | 55.00 k shares | 0.59 | Common equity | Long | Bermuda |
ROG-SE Roche Holding AG | 579.68 k | 16.00 k shares | 0.56 | Common equity | Long | Switzerland |
AUPH Aurinia Pharmaceuticals Inc | 449.50 k | 50.00 k shares | 0.43 | Common equity | Long | Canada |
VTRS Viatris Inc | 379.05 k | 35.00 k shares | 0.36 | Common equity | Long | USA |
VALN Valneva SE | 352.93 k | 34.30 k shares | 0.34 | Common equity | Long | France |
NARI Inari Medical Inc | 324.60 k | 5.00 k shares | 0.31 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 236.20 k | 10.00 k shares | 0.23 | Common equity | Long | USA |
VTYX Ventyx Biosciences Inc | 24.70 k | 10.00 k shares | 0.02 | Common equity | Long | USA |
FID-MM GOVT-I | 1.37 | 1.37 principal | 0.00 | Short-term investment vehicle | Long | USA |
AMRYT PHARMA 2 -CVR
|
0 | 300.00 k shares | 0.00 | Common equity | Long | USA |
AMRYT PHARMA 1 -CVR
|
0 | 300.00 k shares | 0.00 | Common equity | Long | USA |